<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 28.2: Multimorbidity & Polypharmacy Management</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - DEEP BLUE theme for Crisis Management */
        .module-header {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list li {
            margin: 0;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #1e3a8a;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #1e3a8a;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #eff6ff;
            border: 2px solid #3b82f6;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'ðŸŽ¯';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #1e3a8a;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        h3 {
            font-size: 20px;
            color: #3b82f6;
            margin: 30px 0 15px 0;
            font-weight: 600;
        }

        /* Paragraphs & Text */
        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        .highlight {
            background: linear-gradient(180deg, transparent 60%, #e0e7ff 60%);
            padding: 0 4px;
            font-weight: 500;
            color: #1e3a8a;
        }

        /* Statistics Box */
        .stats-box {
            background: linear-gradient(135deg, #1e3a8a 0%, #1e40af 100%);
            padding: 40px;
            border-radius: 16px;
            margin: 35px 0;
            color: white;
        }

        .stats-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(180px, 1fr));
            gap: 25px;
        }

        .stat-item {
            text-align: center;
        }

        .stat-number {
            font-size: 36px;
            font-weight: 700;
            margin-bottom: 8px;
            display: block;
        }

        .stat-label {
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 1px;
            opacity: 0.9;
        }

        /* Comparison Table */
        .data-table-container {
            overflow-x: auto;
            margin: 30px 0;
            border-radius: 12px;
            border: 1px solid #e5e7eb;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
            text-align: left;
        }

        th {
            background: #f3f4f6;
            padding: 15px;
            font-weight: 600;
            color: #1e3a8a;
            border-bottom: 2px solid #e5e7eb;
        }

        td {
            padding: 15px;
            border-bottom: 1px solid #e5e7eb;
            vertical-align: top;
        }

        tr:last-child td {
            border-bottom: none;
        }

        /* Case Study Box */
        .case-study {
            background: #f9fafb;
            border-radius: 16px;
            margin: 40px 0;
            overflow: hidden;
            border: 1px solid #e5e7eb;
        }

        .case-study-header {
            background: #1e3a8a;
            padding: 20px 30px;
            color: white;
        }

        .case-study-content {
            padding: 30px;
        }

        .patient-profile {
            background: white;
            padding: 20px;
            border-radius: 10px;
            margin-bottom: 20px;
            border: 1px solid #eee;
        }

        /* Check Understanding */
        .check-understanding {
            background: #fdfbf7;
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .reveal-btn {
            background: #1e3a8a;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            cursor: pointer;
            margin-top: 10px;
        }

        .answer-text {
            display: none;
            margin-top: 15px;
            padding: 15px;
            background: #f0fdf4;
            border-radius: 8px;
            color: #166534;
        }

        /* Takeaways Box */
        .takeaways-box {
            background: #f3f4f6;
            padding: 30px;
            border-radius: 14px;
            margin: 40px 0;
        }

        .takeaways-box h4 {
            color: #1e3a8a;
            margin-top: 0;
        }

        /* References Box */
        .references-box {
            background: #f9fafb;
            padding: 30px;
            border-radius: 14px;
            font-size: 14px;
            color: #666;
            margin-top: 50px;
        }

        .references-box h4 {
            color: #333;
            margin-top: 0;
            text-transform: uppercase;
            font-size: 12px;
            letter-spacing: 1px;
        }

        .references-box ul {
            padding-left: 20px;
            margin-bottom: 0;
        }

        .references-box li {
            margin-bottom: 8px;
        }

        /* Footer */
        .lesson-footer {
            text-align: center;
            padding: 40px 0;
            border-top: 1px solid #eee;
            margin-top: 40px;
        }

        .footer-logo {
            max-width: 140px;
            opacity: 0.8;
            margin-bottom: 10px;
        }

        .copyright {
            font-size: 12px;
            color: #999;
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 28: L3: Crisis & Complex Cases</p>
            <h1 class="lesson-title">Lesson 2: Multimorbidity & Polypharmacy Management</h1>
            <div class="lesson-meta">
                <span class="meta-item">35 min read</span>
                <span class="meta-item">Level 3 Practitioner Content</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#section1"><span class="section-num">1</span>Defining the Complex Case</a></li>
                <li><a href="#section2"><span class="section-num">2</span>The Polypharmacy Epidemic</a></li>
                <li><a href="#section3"><span class="section-num">3</span>Nutrient Depletion Pathways</a></li>
                <li><a href="#section4"><span class="section-num">4</span>Adjusting the 'S' Pillar</a></li>
                <li><a href="#section5"><span class="section-num">5</span>Collaborative Care Models</a></li>
                <li><a href="#section6"><span class="section-num">6</span>The Triage of A.G.E.L.E.S.S.</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Master the navigation of "Complex Cases" involving 3+ co-occurring chronic conditions.</li>
                <li>Identify key nutrient depletions caused by common longevity-related medications (Statins, Metformin, ACE Inhibitors).</li>
                <li>Learn to adjust the <span class="highlight">Supplements & Biohacks</span> pillar to mitigate contraindications.</li>
                <li>Develop a collaborative communication framework for multi-disciplinary medical teams.</li>
                <li>Apply strategic prioritization to the A.G.E.L.E.S.S. Protocolâ„¢ when multiple biological systems are failing.</li>
            </ul>
        </div>

        <h2 id="section1">1. Defining the 'Complex Case' in Longevity</h2>
        <p>In the earlier modules of the AccrediPro curriculum, we often focused on optimizing the "well" client or the "pre-symptomatic" individual. However, as an L3 Practitioner, you will inevitably encounter the <span class="highlight">Multimorbid Client</span>â€”individuals presenting with three or more chronic conditions simultaneously. This is no longer the exception; it is the statistical reality of the aging population.</p>

        <p>Multimorbidity is defined as the co-occurrence of two or more chronic conditions in one person. In longevity coaching, the "Complex Case" typically involves a triad of metabolic, cardiovascular, and musculoskeletal dysfunction. For example, a client may present with Type 2 Diabetes (T2D), Coronary Artery Disease (CVD), and Osteoporosis.</p>

        <div class="stats-box">
            <div class="stats-grid">
                <div class="stat-item">
                    <span class="stat-number">67%</span>
                    <span class="stat-label">Adults 65+ with 2+ Chronic Conditions</span>
                </div>
                <div class="stat-item">
                    <span class="stat-number">3.4x</span>
                    <span class="stat-label">Increased risk of frailty with 3+ conditions</span>
                </div>
                <div class="stat-item">
                    <span class="stat-number">42%</span>
                    <span class="stat-label">Clients over 60 taking 5+ medications</span>
                </div>
            </div>
        </div>

        <p>The challenge for the Longevity Coach is that interventions for one condition may exacerbate another. High-intensity resistance training (Exercise Pillar) is vital for Osteoporosis but may pose an acute risk for a client with advanced CVD or uncontrolled hypertension. This requires a shift from "Protocol Application" to <span class="highlight">Clinical Triage</span>.</p>

        <h2 id="section2">2. The Polypharmacy Awareness Framework</h2>
        <p><span class="highlight">Polypharmacy</span> is generally defined as the regular use of five or more medications. While medications are often life-saving, their cumulative effect can lead to what is known as the "Prescribing Cascade"â€”where a new medication is prescribed to treat the side effects of a previous one, misinterpreted as a new medical condition.</p>

        <p>As a Longevity Coach, your role is not to diagnose or alter prescriptions but to be the <span class="highlight">Safety Sentinel</span>. You must understand how these drugs interact with the biological pathways we aim to optimize through the A.G.E.L.E.S.S. Protocolâ„¢. Many "longevity drugs" (like Metformin) or "standard of care" drugs (like Statins) have significant impacts on mitochondrial function and nutrient status.</p>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Medication Class</th>
                        <th>Common Examples</th>
                        <th>Longevity Implication</th>
                        <th>Coaching Consideration</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>Statins</strong></td>
                        <td>Atorvastatin, Simvastatin</td>
                        <td>Inhibits HMG-CoA reductase; depletes CoQ10.</td>
                        <td>Monitor for myalgia (muscle pain) affecting the Exercise pillar.</td>
                    </tr>
                    <tr>
                        <td><strong>Biguanides</strong></td>
                        <td>Metformin</td>
                        <td>Inhibits Complex I of mitochondria; depletes B12.</td>
                        <td>Watch for neuropathy symptoms and megaloblastic anemia signs.</td>
                    </tr>
                    <tr>
                        <td><strong>ACE Inhibitors</strong></td>
                        <td>Lisinopril, Enalapril</td>
                        <td>Alters electrolyte balance; depletes Zinc.</td>
                        <td>Zinc deficiency can impair immune health and taste (impacting Eat pillar).</td>
                    </tr>
                    <tr>
                        <td><strong>PPIs</strong></td>
                        <td>Omeprazole, Nexium</td>
                        <td>Hypochlorhydria; impairs Mg, B12, and Ca absorption.</td>
                        <td>Critical for clients with Osteoporosis (Gut-Bone axis).</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <h2 id="section3">3. Nutrient Depletion Pathways</h2>
        <p>The A.G.E.L.E.S.S. Protocolâ„¢ relies on cellular "fuel" to drive epigenetic repair and metabolic flexibility. Polypharmacy often creates a "hidden hunger" where the client is calorically sufficient but cellularly starved. A 2022 cross-sectional study found that 38% of elderly patients on polypharmacy had at least one clinically significant micronutrient deficiency directly attributable to their medication regimen.</p>

        <h3>The Metformin-B12 Connection</h3>
        <p>Metformin is a cornerstone of longevity protocols due to its AMPK-activating properties. However, it interferes with the calcium-dependent absorption of the B12-intrinsic factor complex in the terminal ileum. Chronic use (3+ years) is associated with a 10-30% increase in the risk of B12 deficiency. For a longevity client, B12 deficiency elevates <span class="highlight">Homocysteine</span>, a potent driver of neurodegeneration and vascular aging.</p>

        <h3>The Statin-Mitochondria Paradox</h3>
        <p>While statins reduce LDL-C and cardiovascular events, they also inhibit the production of mevalonate, a precursor not just for cholesterol, but for <span class="highlight">Coenzyme Q10 (CoQ10)</span>. CoQ10 is essential for the electron transport chain. Depletion leads to mitochondrial dysfunction, often manifesting as statin-associated muscle symptoms (SAMS). This creates a barrier to the Exercise Pillar, accelerating Sarcopenia.</p>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">ðŸ“‹</div>
                <div>
                    <p class="box-label">Case Study 1: The Fatigue Cascade</p>
                    <p class="subtitle">Managing Polypharmacy in a Metabolic Case</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div>
                        <h4>Arthur, 72</h4>
                        <p>Conditions: T2D, Hypertension, Hyperlipidemia. Medications: Metformin (2000mg), Lisinopril, Atorvastatin.</p>
                    </div>
                </div>
                <p><strong>Presentation:</strong> Arthur reported "heavy legs" during his Zone 2 walks and increasing peripheral numbness. He was considering quitting the Exercise Pillar due to lack of motivation and physical discomfort.</p>
                <p><strong>Intervention:</strong> The coach identified potential B12 and CoQ10 depletion. Arthur was encouraged to request a serum B12 and Methylmalonic Acid (MMA) test from his GP. Results showed B12 at 210 pg/mL (borderline low). With GP approval, the coach integrated 1000mcg Methylcobalamin and 200mg Ubiquinol (active CoQ10).</p>
                <p><strong>Outcome:</strong> Within 6 weeks, Arthurâ€™s myalgia resolved. His "heavy legs" disappeared, allowing him to increase his VO2 Max training frequency. His HbA1c remained stable, but his quality of life scores (SF-36) improved by 40%.</p>
            </div>
        </div>

        <h2 id="section4">4. Adjusting the 'S' Pillar: Safety & Contraindications</h2>
        <p>In complex cases, the <span class="highlight">Supplements & Biohacks</span> pillar must be the most conservative. The "more is better" approach to longevity supplements (e.g., stacking NMN, Quercetin, Resveratrol, and Berberine) can be dangerous in the context of polypharmacy due to <span class="highlight">Cytochrome P450 (CYP450)</span> enzyme inhibition or induction.</p>

        <p>Many longevity supplements use the same metabolic pathways as pharmaceutical drugs. For example:</p>
        <ul>
            <li><strong>Berberine:</strong> A potent glucose-lowering agent that can cause hypoglycemia if stacked with insulin or sulfonylureas. It also inhibits CYP3A4, which can increase the blood concentration of certain statins to toxic levels.</li>
            <li><strong>Vitamin K2:</strong> Essential for the Gut-Bone axis and arterial decalcification, but strictly contraindicated for clients on Warfarin (Coumadin) due to its role in the clotting cascade.</li>
            <li><strong>High-Dose Omega-3s:</strong> Can have an anti-platelet effect. While beneficial for longevity, it may increase bleeding risk in clients already taking Aspirin, Clopidogrel, or Apixaban.</li>
        </ul>

        <h2 id="section5">5. Collaborative Care Models</h2>
        <p>The Longevity Coach is the "Integrative Hub." You often spend more time with the client than their entire medical team combined. However, you must operate within a strict <span class="highlight">Scope of Practice</span>. Communication with a client's multi-disciplinary team (MDT) should be professional, data-driven, and deferential to clinical authority.</p>

        <h3>The "Longevity Report" Strategy</h3>
        <p>When working with complex cases, provide the client with a "Coaching Summary" they can hand to their doctor. This should include:</p>
        <ol>
            <li><strong>Current Lifestyle Interventions:</strong> (e.g., "Client is performing 150 min/week of Zone 2 cardio").</li>
            <li><strong>Observed Symptoms:</strong> (e.g., "Client reports muscle soreness following statin initiation").</li>
            <li><strong>Proposed Supplement Adjustments:</strong> (e.g., "We are discussing the addition of CoQ10 to support mitochondrial health; please advise on contraindications").</li>
        </ol>
        <p>This approach positions you as an ally to the physician rather than a competitor. It ensures the medical team is aware of the "biohacks" the client may be attempting behind closed doors.</p>

        <h2 id="section6">6. Strategic Prioritization: The Triage of A.G.E.L.E.S.S.</h2>
        <p>When a client is failing in multiple systems, you cannot optimize everything at once. You must determine which pillar takes precedence based on the <span class="highlight">Hierarchy of Vitality</span>.</p>

        <div class="principle-card">
            <div class="principle-title">Level 1: Metabolic & Glycemic Stability (Assess & Eat)</div>
            <p class="principle-text">If blood glucose is swinging wildly, no amount of Zone 2 training will overcome the inflammatory damage. Stabilizing the "Eat" pillar and monitoring "Assess" biomarkers is the first priority.</p>
        </div>

        <div class="principle-card">
            <div class="principle-title">Level 2: Structural Integrity (Exercise)</div>
            <p class="principle-text">Once metabolic crisis is averted, preventing the "Fall and Fracture" cycle is paramount. Resistance training for Sarcopenia reversal becomes the secondary focus.</p>
        </div>

        <div class="principle-card">
            <div class="principle-title">Level 3: Advanced Optimization (Supplements & Biohacks)</div>
            <p class="principle-text">Senolytics and NAD+ boosters are the "icing on the cake." They should only be introduced once the foundational pillars are stable and medications are accounted for.</p>
        </div>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <p class="box-subtitle">Test your knowledge on complex case management.</p>

            <div class="question-item">
                <div class="question-number">1</div>
                <p class="question-text">A client on Metformin for 5 years presents with new-onset brain fog and tingling in the feet. Which A.G.E.L.E.S.S. pillar and specific depletion should you investigate first?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">
                    Investigate the <strong>Assess (A)</strong> pillar for B12 levels. Metformin is known to deplete Vitamin B12, which can cause both cognitive decline (brain fog) and peripheral neuropathy (tingling).
                </div>
            </div>

            <div class="question-item">
                <div class="question-number">2</div>
                <p class="question-text">Why is Berberine considered a high-risk supplement in a polypharmacy case involving Statins?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">
                    Berberine inhibits the <strong>CYP3A4 enzyme</strong>. Since many statins are metabolized by this same enzyme, Berberine can slow their clearance, leading to higher-than-intended drug levels in the blood and increasing the risk of muscle toxicity.
                </div>
            </div>
        </div>

        <div class="takeaways-box">
            <h4>Lesson Takeaways</h4>
            <ul>
                <li><strong>Multimorbidity is the Norm:</strong> Practitioners must be prepared for clients with 3+ conditions requiring systemic triage.</li>
                <li><strong>The Sentinel Role:</strong> Longevity coaches monitor for "Prescribing Cascades" and nutrient depletions like B12 (Metformin) and CoQ10 (Statins).</li>
                <li><strong>Safety Over Optimization:</strong> In polypharmacy, the 'S' pillar must be adjusted to avoid CYP450 enzyme interactions.</li>
                <li><strong>Collaborative Communication:</strong> Use structured "Longevity Reports" to keep the client's medical team informed and supportive.</li>
                <li><strong>Prioritization:</strong> Always stabilize metabolic health (Glycemic control) before moving to advanced biohacking.</li>
            </ul>
        </div>

        <div class="references-box">
            <h4>References & Further Reading</h4>
            <ul>
                <li>Menti et al. (2023). "Polypharmacy and health outcomes in older adults: A systematic review and meta-analysis." <i>Journal of Internal Medicine.</i></li>
                <li>Reinstatler et al. (2022). "Association of Metformin Use with Vitamin B12 Deficiency and Peripheral Neuropathy." <i>Diabetes Care.</i></li>
                <li>Qu et al. (2021). "The effect of statins on mitochondrial pathways: A focus on Coenzyme Q10." <i>Free Radical Biology and Medicine.</i></li>
                <li>Winston et al. (2024). "Drug-Nutrient Interactions in the Aging Population: A Clinical Guide for Practitioners." <i>Nutrients.</i></li>
                <li>World Health Organization (2023). "Multimorbidity: Technical Series on Safer Primary Care." <i>WHO Guidelines.</i></li>
            </ul>
        </div>

        <footer class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy | Anti-Aging & Longevity Coach Certification</p>
            <p class="copyright">&copy; 2025 AccrediPro Academy. All rights reserved. Professional Use Only.</p>
        </footer>
    </div>
</body>

</html>